Substituted cyclopentadienyl compounds for the treatment of inflammation
    2.
    发明授权
    Substituted cyclopentadienyl compounds for the treatment of inflammation 失效
    用于治疗炎症的取代的环戊二烯基化合物

    公开(公告)号:US5418254A

    公开(公告)日:1995-05-23

    申请号:US238101

    申请日:1994-05-04

    摘要: A class of 2,3-substituted cyclopenta-2,4-dienyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR1## wherein each of R.sup.1 and R.sup.2 is independently selected from hydrido, lower alkyl, lower hydroxyalkyl, halo, lower haloalkyl, lower alkoxycarbonyl and carboxyl; and wherein each of R.sup.3 through R.sup.12 is independently selected from hydrido, halo, lower alkyl, lower alkylthio, cyano, hydroxyl, mercapto, lower haloalkyl, lower haloalkoxy, lower alkoxy, lower hydroxyalkyl, lower alkoxyalkyl, lower alkylsulfonyl, lower haloalkylsulfonyl and sulfamyl; provided R.sup.5 and R.sup.10 are not both hydrido or methoxy; or a pharmaceutically suitable salt or prodrug thereof.

    摘要翻译: 描述了一类2,3-取代的环戊二烯-2,4-二烯基化合物用于治疗炎症和炎症相关疾病。 特别感兴趣的化合物由式II定义:倾向选自氢化,低级烷基,低级羟烷基,卤素,低级卤代烷基,低级烷氧基羰基和羧基; R 3至R 12各自独立地选自氢,卤素,低级烷基,低级烷硫基,氰基,羟基,巯基,低级卤代烷基,低级卤代烷氧基,低级烷氧基,低级羟烷基,低级烷氧基烷基,低级烷基磺酰基,低级卤代烷基磺酰基和氨磺酰基。 条件是R 5和R 10不同时为氢或甲氧基; 或其药学上合适的盐或前药。

    Pyridyl substituted cyclopentadienes for the treatment of inflamation
    3.
    发明授权
    Pyridyl substituted cyclopentadienes for the treatment of inflamation 失效
    吡啶基取代环戊二烯用于治疗炎症

    公开(公告)号:US5576339A

    公开(公告)日:1996-11-19

    申请号:US417341

    申请日:1995-04-05

    摘要: A class of 2,3-substituted cyclopenta-2,4-dienyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR1## wherein each of R.sup.1 and R.sup.2 is independently selected from hydrido, lower alkyl, lower hydroxyalkyl, halo, lower haloalkyl, lower alkoxycarbonyl and carboxyl; and wherein each of R.sup.3 through R.sup.12 is independently selected from hydrido, halo, lower alkyl, lower alkylthio, cyano, hydroxyl, mercapto, lower haloalkyl, lower haloalkoxy, lower alkoxy, lower hydroxyalkyl, lower alkoxyalkyl, lower alkylsulfonyl, lower haloalkylsulfonyl and sulfamyl; provided R.sup.5 and R.sup.10 are not both hydrido or methoxy; or a pharmaceutically suitable salt or prodrug thereof.

    摘要翻译: 描述了一类2,3-取代的环戊二烯-2,4-二烯基化合物用于治疗炎症和炎症相关疾病。 特别感兴趣的化合物由式II定义:倾向选自氢化,低级烷基,低级羟烷基,卤素,低级卤代烷基,低级烷氧基羰基和羧基; R 3至R 12各自独立地选自氢,卤素,低级烷基,低级烷硫基,氰基,羟基,巯基,低级卤代烷基,低级卤代烷氧基,低级烷氧基,低级羟烷基,低级烷氧基烷基,低级烷基磺酰基,低级卤代烷基磺酰基和氨磺酰基。 条件是R 5和R 10不同时为氢或甲氧基; 或其药学上合适的盐或前药。

    Substituted spirodienes for the treatment of inflammation
    4.
    发明授权
    Substituted spirodienes for the treatment of inflammation 失效
    取代螺旋体用于治疗炎症

    公开(公告)号:US5672627A

    公开(公告)日:1997-09-30

    申请号:US677263

    申请日:1996-07-09

    摘要: A class of substituted spirodienes is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula III: ##STR1## wherein R.sup.3 is methylsulfonyl or sulfamyl; and wherein R.sup.8 is selected from hydrido, fluoro, chloro, bromo, iodo, methyl, ethyl, n-propyl, isopropyl, butyl, tert-butyl, isobutyl, methoxy, ethoxy, propoxy, butoxy, hydroxyl, mercapto, methylthio, ethylthio, cyano, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, pentafluoroethyl, heptafluoropropyl, difluorochloromethyl, dichlorofluoromethyl, difluoroethyl, difluoropropyl, dichloroethyl, dichloropropyl, trifluoromethoxy, hydroxymethyl, methoxymethyl and ethoxymethyl; or a pharmaceutically-acceptable salt thereof.

    摘要翻译: 描述了一类取代的螺旋体用于治疗炎症和炎症相关疾病。 特别感兴趣的化合物由式III定义:其中R 3是甲基磺酰基或磺酰氨基; 甲基,乙基,正丙基,异丙基,丁基,叔丁基,异丁基,甲氧基,乙氧基,丙氧基,丁氧基,羟基,巯基,甲硫基,乙硫基, 氰基,氟甲基,二氟甲基,三氟甲基,氯甲基,二氯甲基,三氯甲基,五氟乙基,七氟丙基,二氟氯甲基,二氯氟甲基,二氟乙基,二氟丙基,二氯乙基,二氯丙基,三氟甲氧基,羟甲基,甲氧基甲基和乙氧基甲基; 或其药学上可接受的盐。